Open original FDA record ↗Recall record
- FDA identifier
- Z-1685-2017
- Company in FDA record
- Focus Diagnostics Inc
- FDA classification date
- Mar 27, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
After a submission for CLIA database update from Focus Diagnostics to DiaSorin Molecular,the company found that their Legionella IFA device (IF0950) is not 510(k) exempt.
Source facts
- Action
- Focus Diagnostics/DiaSorin Molecular is issuing a medical device correction for the Legionella IFA (Immuno Fluoresence Assay). On February 1, 2017, the firm was notified that the Legionella IFA was not properly classified according to 21 CFR Part 807. The product is being withdrawn from the market. Use of the product should be immediately discontinued, and any remaining inventory should be immediately destroyed. The firm sent notice to its consignees, which should be reviewed with the facility's laboratory or mediclal director. Patient results obtained with all lots of the affected product should be evaluated by the clinician and if recommended, retested by another method.
- Initiated
- 2017-02-15
- Root cause
- No Marketing Application
- Terminated
- 2017-04-13
- Distribution
- Product was distributed to three testing laboratories in California, New Jersey and Virginia
- Recall number
- Z-1685-2017
- Recall status
- Terminated
- CDRH record ID
- 153686
- FDA classified
- 2017-03-27
- Recall event number
- 76619